Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: OraSure Technologies, Inc.

Market Cap 288M 249M 230M 215M 403M 27.42B 409M 2.71B 1.06B 13.35B 1.08B 1.06B 46.21B P/E Ratio 2026 *
-3.99x
P/E Ratio 2027 * -5.11x
Enterprise Value 288M 249M 230M 215M 403M 27.42B 409M 2.71B 1.06B 13.35B 1.08B 1.06B 46.21B EV / Sales 2026 *
2.41x
EV / Sales 2027 * 2.26x
Free-Float
93.62%
Yield 2026 *
-
Yield 2027 * -
1 day-0.95%
1 week+2.72%
Current month-3.49%
1 month+39.73%
3 months+34.30%
6 months+66.67%
Current year+71.49%
1 week 4
Extreme 4
4.3
1 month 2.92
Extreme 2.92
4.33
Current year 2.33
Extreme 2.33
4.33
1 year 2.08
Extreme 2.08
4.33
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
13.57
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 04/06/2022
Director of Finance/CFO 54 08/08/2022
Chief Tech/Sci/R&D Officer - 01/12/2024
Director TitleAgeSince
Director/Board Member 59 01/06/2020
Director/Board Member 66 08/11/2021
Director/Board Member 52 04/06/2022
Date Insider Type Main position Quantity % Market Cap.
06-03Free

Director

46,106 0.0670%
06-03Free

Chairman

46,106 0.0670%
06-03Free

Director

46,106 0.0670%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%+2.72%+41.64%-22.57% 288M
-1.50%-3.63%-35.68%-13.45% 156B
-0.19%-2.01%-9.57%-5.05% 103B
-0.89%+2.17%-4.76%+56.70% 54.77B
+3.00%-0.04%+54.23%+54.37% 53.52B
-1.11%-3.31%-16.23%-41.71% 40.6B
-2.90%+8.81% - - 31.4B
+0.87%+3.25%-9.20%-40.73% 29.04B
+1.23%+4.25%+45.77%-8.26% 23.34B
-2.85%-3.36%-17.02%-0.74% 20.81B
Average -0.65%+1.93%+5.47%-2.38% 51.3B
Weighted average by Cap. -0.59%+1.04%-8.55%+0.63%

Financials

2026 *2027 *
Net sales 120M 103M 95.26M 89.17M 167M 11.38B 170M 1.12B 439M 5.54B 449M 440M 19.17B 128M 110M 102M 95.24M 178M 12.15B 181M 1.2B 468M 5.91B 480M 470M 20.48B
Net income -73.68M -63.64M -58.64M -54.89M -103M -7B -104M -692M -270M -3.41B -277M -271M -11.8B -57.65M -49.79M -45.88M -42.95M -80.48M -5.48B -81.73M -542M -211M -2.67B -216M -212M -9.23B
Net Debt - -
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
12/06/26 4.180 $ -0.24% 437,544
11/06/26 4.190 $ +3.97% 776,017
10/06/26 4.030 $ -4.95% 716,979
09/06/26 4.240 $ +2.17% 748,278
08/06/26 4.150 $ +2.72% 808,637
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.190USD
Average target price
4.750USD
Spread / Average Target
+13.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OSUR Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!